WallStSmart

HIVE Digital Technologies Ltd (HIVE)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 703526% more annual revenue ($2.33T vs $331.30M). NMR leads profitability with a 17.3% profit margin vs -98.5%. NMR earns a higher WallStSmart Score of 84/100 (A-).

HIVE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 2/9Altman Z: 1.70

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HIVE2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
73.5%10/10

Revenue surging 73.5% year-over-year

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

HIVE4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.704/10

Distress zone — elevated risk

Market CapQuality
$746.03M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-76.3%2/10

ROE of -76.3% — below average capital efficiency

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : HIVE

The strongest argument for HIVE centers on Revenue Growth, Price/Book. Revenue growth of 73.5% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : HIVE

The primary concerns for HIVE are Altman Z-Score, Market Cap, Piotroski F-Score.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

HIVE profiles as a hypergrowth stock while NMR is a growth play — different risk/reward profiles.

HIVE carries more volatility with a beta of 3.70 — expect wider price swings.

HIVE is growing revenue faster at 73.5% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 36/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HIVE Digital Technologies Ltd

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Aerohive Networks, Inc. designs and develops cloud networks and enterprise Wi-Fi solutions in the Americas, Europe, the Middle East and Africa, and Asia Pacific. The company is headquartered in Milpitas, California.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?